PubMed:32784110 / 1377-1585 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T10","span":{"begin":118,"end":133},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma49893"}],"text":"All patients had evidence of chronic cardiac disease, including myocardial hypertrophy (13/14, 92.9%), mild to marked coronary artery atherosclerosis (14/14, 100%) and focal myocardial fibrosis (3/14, 21.4%)."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T9","span":{"begin":118,"end":133},"obj":"Body_part"},{"id":"T10","span":{"begin":127,"end":133},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"uberon_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/UBERON_0001621"},{"id":"A10","pred":"uberon_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/UBERON_0001637"}],"text":"All patients had evidence of chronic cardiac disease, including myocardial hypertrophy (13/14, 92.9%), mild to marked coronary artery atherosclerosis (14/14, 100%) and focal myocardial fibrosis (3/14, 21.4%)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T12","span":{"begin":37,"end":52},"obj":"Disease"},{"id":"T13","span":{"begin":134,"end":149},"obj":"Disease"}],"attributes":[{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005267"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0005311"}],"text":"All patients had evidence of chronic cardiac disease, including myocardial hypertrophy (13/14, 92.9%), mild to marked coronary artery atherosclerosis (14/14, 100%) and focal myocardial fibrosis (3/14, 21.4%)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T22","span":{"begin":127,"end":133},"obj":"http://purl.obolibrary.org/obo/UBERON_0001637"},{"id":"T23","span":{"begin":127,"end":133},"obj":"http://www.ebi.ac.uk/efo/EFO_0000814"}],"text":"All patients had evidence of chronic cardiac disease, including myocardial hypertrophy (13/14, 92.9%), mild to marked coronary artery atherosclerosis (14/14, 100%) and focal myocardial fibrosis (3/14, 21.4%)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"74","span":{"begin":4,"end":12},"obj":"Species"},{"id":"75","span":{"begin":37,"end":52},"obj":"Disease"},{"id":"76","span":{"begin":64,"end":86},"obj":"Disease"},{"id":"77","span":{"begin":118,"end":149},"obj":"Disease"},{"id":"78","span":{"begin":168,"end":193},"obj":"Disease"}],"attributes":[{"id":"A74","pred":"tao:has_database_id","subj":"74","obj":"Tax:9606"},{"id":"A75","pred":"tao:has_database_id","subj":"75","obj":"MESH:D006331"},{"id":"A76","pred":"tao:has_database_id","subj":"76","obj":"MESH:D006332"},{"id":"A77","pred":"tao:has_database_id","subj":"77","obj":"MESH:D003324"},{"id":"A78","pred":"tao:has_database_id","subj":"78","obj":"MESH:D005355"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"All patients had evidence of chronic cardiac disease, including myocardial hypertrophy (13/14, 92.9%), mild to marked coronary artery atherosclerosis (14/14, 100%) and focal myocardial fibrosis (3/14, 21.4%)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T5","span":{"begin":118,"end":149},"obj":"Phenotype"},{"id":"T6","span":{"begin":174,"end":193},"obj":"Phenotype"}],"attributes":[{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0001677"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0001685"}],"text":"All patients had evidence of chronic cardiac disease, including myocardial hypertrophy (13/14, 92.9%), mild to marked coronary artery atherosclerosis (14/14, 100%) and focal myocardial fibrosis (3/14, 21.4%)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T11","span":{"begin":0,"end":208},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"All patients had evidence of chronic cardiac disease, including myocardial hypertrophy (13/14, 92.9%), mild to marked coronary artery atherosclerosis (14/14, 100%) and focal myocardial fibrosis (3/14, 21.4%)."}